³¯§ÓºÓ Âå®v
¿éºëºÞµ²²Ï¤â³N¬O¤HÃþ¥Ã¤[©ÊÁ×¥¥ªº¤èªk¡C®Ú¾Ú¬ü°êªº²Îp¡A¿éºëºÞµ²²Ï¤â³N¦b¬ü°ê¨Ã¥¼¼W¥[¡Aºû«ù¦b¨C¦~500,000Ó¯f¨Ò¡A¦ýn¨D¿éºëºÞ§k¦X³Nªº¯f¨Ò«o«ùÄò¼W¥[¡A¬ù2%
¨ì 6% ªº¿éºëºÞµ²²Ï¯f¨Òn¨D«ì´_¿éºëºÞªººZ³q¡C1991 ¦~¦b¬ü°ê¡AVasovasostomy
Study Group´¿³ø§i1469 Ó±µ¨ü¿éºëºÞ§k¦X³Nªº¯f¨Ò¡A³o¨ä¤¤¬ù 75%
¬O¦]¬°¦A±B¡A10% ¦]¬°¤Ò©d·Qn¦A¥Í¤p«Ä¡A2.6%
¬O¦]¬°¤p«Ä¦º¤`©Îªk«ßÄ~©Ó¤Wªº°ÝÃD¡A¨ä¥¦«h¦]¿éºëºÞµ²²Ï«á³±Ån¯kµh¡A©v±Ð«H¥õªº§ïÅÜ»P¤ß¸Ì¤Wªº¦]¯À¡C¦b¥xÆW¥Ñ©óÂ÷±B²vªº¼W¥[¡Aªc§¿¬ìÂå®v»Ý±¹ï¦¹¿éºëºÞ§k¦XÅã·L¤â³Nªº¾÷·|¥²¤j¤jªº¼W¥[¡Cn¦p¦ó¦b
0.3m ¨ì 0.4mm
ªº¿éºëºÞµÄ¶¡°µ¦nºë½T¥B¤£º¯º|ªºÅã·L¿éºëºÞ§k¦X³N¡Aªº½T¬Oªc§¿¬ìÂå®vªº¤@¤j¬D¾Ô¡C¦ý¬O¦¨¥\±o±µ³q¿éºëºÞ¨Ã¤£¤@©w«OÃÒ¯à°÷Ãh¥¥¡A¦]¬°ÁÙ¦³«Ü¦h¦]¯À·|¼vÅTÃh¥¥ªº¦¨¥\¡C
¿éºëºÞµ²²Ï¤â³N¹ï¿éºëºÞ»P¸A¤Yªº¼vÅT¡G
¿éºëºÞµ²²Ï·|¸g¥Ñ¦UºØ¤£¦Pªº³~®|¼vÅT¥Í´Þ¯à¤O¡C³o¨ä¤¤¥]¬A¿éºëºÞ¤º½¤¤W¥Öªº§ïÅÜ¡A»P¿éºëºÞµÄ¤ºÀ£¤O¼W¥[¹ï¸A¤Y¡B°Æ¸A¤Y¡B¿éºëºÞªº¼vÅT¡CBagshaw
HA.¦b 1980 ³ø§i¿éºëºÞµ²²Ï«á10 ¦~¡A¸A¤Y¤Á¤ùÅã¥Ü 93.5% (58/62)¤´¨ã¦³¥¿±`ªº³yºë¯à¤O
(Spermatogenesis)¡F¦ý¦b¹q¤lÅã·LÃè¤U¤´¦³ 23%
ªº¯f¤H·|¦b¸A¤Y¤Á¤ù¤WÅã¥Ü¥X©úÅ㪺Åã·LÅܤÆ(Jarrow JP,1985)¡C¦]¦¹¿éºëºÞ§k¦X³N§Þ³N¤Wªº§xÃø¥[¤W¬ù
50% - 60%ªº¯f¨Ò©ó¦å²M¤º¤´¨ã¦³§Üºë¤l§ÜÅé (Antisperm antibody)
µ¥µ¥¡A³o¨Ç³£·|¼vÅTºë¤lªº¬¡°Ê¤O¡Bºë¤lªº¾®¶° (Agglutination),»Pºë¤lªº
Capacitation¡A¦]¦¹¦Ó¼vÅT¨ì¿éºëºÞ§k¦XÅã·L¤â³NÃh¥¥ªº¦¨¥\²v¡C¤×¨ä¬O
Belker AM. ´¿©ó 1983
¦~³ø§i¿éºëºÞµ²²Ï·|ÀHµÛµ²²Ï®É¶¡¦Ó¼W¥[°Æ¸A¤Y¤ºÀ£¤O¡A³y¦¨°Æ¸A¤Yªºªý¶ë¡A¦Ó»Ý±Ä¥Î¿éºëºÞ°Æ¸A¤Y§k¦XÅã·L¤â³N(Vasoepididymostomy)¡C
³N«eµû¦ô
1).²z¾ÇÀˬd¡G
|
¸A¤Y¡G¸û¤p©Î¸û¬X³nªº¸A¤Y·N¿×µÛ³yºë¯à¤O°§C¡A¦¨¥\¦ÓÃh¥¥ªº¾÷·|
§C¡C |
°Æ¸A¤Y¡G¤£³W«hªº°Æ¸A¤Yµ²¸`(Induration)¡A¥Nªí°Æ¸A¤Y¥i¯à¦³µoª¢
³y¦¨ Secondary °Æ¸A¤Yªý¶ë¡A»Ý±Ä¥Î¿éºëºÞ°Æ¸A¤Y§k¦XÅã·L¤â³N
(Vasoepididymostomy)¤~¯à³º¨ä¥\¡C |
ºë¤l Granuloma¡G¦³¦¹¥Nªíºë¤l´¿¥Ñ¿éºëºÞµ²²Ïªº³¡¦ìº¯º|
(Sperm leakage)¡A¦]¦¹¥i¥H´î¤Ö°Æ¸A¤YªººÞµÄ¤ºÀ£¡A¦Ó¹ïº¸«áºë¤lªº¹w
«á¥i¯à¸û¨Î¡C |
¿éºëºÞ¯Ê·l (Vasal gap)¡G·í¿éºëºÞ¯Ê·l¹Lªø¡A·N¿×µÛª½¦æ¿éºëºÞ¤j³¡
¤À¤w³Q¤Á°£©ÎµÛ¤w¥aºû¤Æ¡A¦]¦¹¤â³N¤Á¤f¥i¯à»Ýn©¹¹«·Ë³¡ªu
¦ù¡A¥H«K§¹¦¨µL±i¤O (Tension free) ªº¿éºëºÞ§k¦X³N¡C |
³±Ån¬Í²ª (Scar)¡G¦b³±Ån©Î¹«·Ë³¡ªº¬Í²ª¥²¶·¥[¥Hª`·N¡A³o´£¥Ü°£¤F
¿éºëºÞµ²²Ïªº³¡¦ì¡A¥i¯àÁÙ¦³¨ä¥¦ªý¶ë³¡¦ì»Ý¸Ñ¨M¡C |
2).¹êÅçÀˬd¡G
ºë¤lÀˬd¡G
Y¦³ºë¤l¦s¦b¡A¥Nªí¤wµo¥Í Microrecanalization.¦b¦¹±¡ªp¤U³Ì¤Ö¦³¤@Ã䦳ºëÂΡA¹w«á¸û¨Î¡CY¾ãÓºë¶qÅé¿nµ}¤Ö¡A¥²¶·¥[¥Hª`·N¦³µL®gºëºÞªý¶ë¡A¶·°µ¨zªù¶WµªiÀˬd
(Transrectal ultrasound) ½T©w¤§¡C
¦å²M¤º§Üºë¤l§ÜÅé (Antisperm antibody)¡G
¥X²{ Antisperm antibody
«h²Å¦X¿éºëºÞªº¦³ªý¶ë±¡ªp¡C³o¤]¥i¯à¼vÅT¨ìºë¤lªº¬¡°Ê¤O¡C
¦å²M¤º FSH¡G
¥Ñ¨ä¹ï¸A¤Y¸û¤p©Î¸û¬X³nªº¯f¤H¡AY´ú¥X FSH
¤É°ª¡A¥i¹w´ú¨ä¸A¤Yªº Spermatogenesis
¸û®t¡A¬Û¹ï¥i¤Ï¬M¥X±N¹w«á¸û®t¡C
¤â³N¤èªk¡G
1).¦¨¥\¤§Æ_¡G
Accurate mucosa-to-mucosa approximation¡G
³q±`ªñºÝ¿éºëºÞ¸û»·ºÝ¼e 3-6 ¿¡A»Ýn®É¥i Spatulate
»·ºÝ¿éºëºÞ¡A¦ýì«h¤W¥H¶ê§ÎºÞµÄ¸û§Q©ó¿éºëºÞ§k¦X³N¡A©Ò¥H·í¿éºëºÞ§k¦X³N¬O¦ì©ó
Convoluted vas ®É¡A¿éºëºÞªº¾î¤Án¯S§Oª`·N¡C
Leakproof anastomosis¡G
ºë¤l¥»¨³q±`¨ã¦³§Ü¤¸©Ê¡A¤]«Ü®e©ö¤Þ°_µoª¢¤ÏÀ³¡A¿éºëºÞ¥»¨¤]¤£¹³¦åºÞ¦³¦å¤pªO¡A¾®¦å¦]¤l¥i¶ñ¶ë¦í§k¦X¯Ê¤f¡A©Ò¥H¿éºëºÞ¤º½¤ªº§¹¾ã©Ê¦b¿éºëºÞ§k¦XÅã·L¤â³N¤¤«D±`«n¡C
Tension-free anastomosis¡G
¦b¦³±i¤O¤Uªº¿éºëºÞ§k¦XÅã·L¤â³N¦bªì´Á¤´¥i¯à¦³ºë¤l¥X²{¡A¦ý³Ì«áºë¤l¼Æ¶q»P¬¡°Ê¤O³£·|°§C¡A¬Æ¦Ü³y¦¨ªý¶ë±¡ªp¡A¤S³y¦¨µLºë¯g¡C¦]¦¹¡A·í¿éºëºÞªø«×¤£°÷®É¥i±N
Convoluted tubule ¤ÀÂ÷°Æ¸A¤Y¥H¼W¥[ªø«×¡A´î¤Ö±i¤O¡C
Good blood supply¡G
¿éºëºÞ¤Á¤f¥²»Ýn¤Á¨ìªº¦³¥¿±`ªº¦å²G¨ÑÀ³³¡¤À¡A¥H§K³y¦¨¤é«á¿éºëºÞªºªý¶ë¡C
Healthy mucosa and muscularis¡G
Y¿éºëºÞ¾îÂ_±ªº¤º½¤ªí²{¥X¯Ü¦Ó¥BµL¼u©Êªº¤º½¤»Pµ¬¦×¼h¡A³Ì¦n¯à¤Á¨ì¸û¥¿±`ªº²Õ´³¡¤À¡A¿éºëºÞ§k¦X³N·U¦X·|¸û¨Î¡C
Good atraumatic anastomotic techniques¡G
¿éºëºÞ§k¦XÅã·L¤â³N³Ì©Èªº´N¬OÁ_¦X¹Lµ{¤¤³y¦¨§k¦X³Bªº¶Ë®`¡A¤×¨ä¬O°wÀY»PÁ_½u¹ï¿éºëºÞªºµõ¶Ë©Î
Backwalling¡C
2).¥¨µø¤â³N¤§¦¨ªG¡G
Phadke (1967)¡G±Ä¥Î¿éºëºÞ Nylon stent ¡A¨ä±µ³q²v 83%¡AÃh¥¥ªº¦¨¥\²v¬°55%
Fallon B. vs.Kessler R. (1981):±Ä¥Î Loupes¨ä±µ³q²v 63% - 92%,Ãh¥¥ªº¦¨¥\²v¬ù¬°
50%¡C
Xie-Yang(1988)¡G¹ï¿éºëºÞµ²²Ï¤Ö©ó¤@¦~ªº¯f¨Ò±Ä¥Î Needle stent¡A¨äµ²ªG°¾°ª¡A¨s¨äì¦]¥i¯à¬O¿éºëºÞµ²²Ï¦~¸ûµu¡Aµ²ªG¸û¦n¡C
3). Åã·L¤â³N¤§¦¨ªG¡G
¡@One-Layer Technique¡G
¨ä±µ³q²v¬° 85%,Ãh¥¥ªº¦¨¥\²v¬ù¬° 50%.
¡@Multilayer Microdot Techique¡G
¡@Two-Layer Technique (Silber,1978),
¡@¡@¦bSilberªº³ø§i¨ä±µ³q²v¬° 91%,Ãh¥¥ªº¦¨¥\²v¬ù¬° 81%¡C
¡@¡@Vasovasostomy Study Group (VSG,1991):¨ä±µ³q²v¬° 85.8%,
¡@¡@Ãh¥¥ªº¦¨¥\²v¬ù¬° 51.2%
Modified One-Layer Technique¡G
¡@¥Î9-0 Nylon sutures ¨ä±µ³q²v¬° 89.1% Ãh¥¥ªº¦¨¥\²v¬ù¬° 56.8% (VSG,1991).
¨ä¥¦¿éºëºÞ§k¦X¤â³N¡G
¡@Rosemberg (1987):¥Î CO2 ¹p®g¨Ó§k¦X¿éºëºÞ¡C¦b¨ä 14Ó¯f¨Ò ¦³ 3
ÓÃh¥¥¡C
¡@Lowen (1988):¥Î Neodymnium-YAG ¹p®g¨Ó§k¦X¿éºëºÞ¡C
¡@Wilson (1991):¥Î Tissue adhesives ¨Ó§k¦X¿éºëºÞ¡C
¤â³Nµ²ªG¡G
¦b¿éºëºÞ§k¦X¤â³N«áºë¤l¼Æ¶q·|ºCºC¼W¥[¡A¤»Ó¤ë«á¹F¨ì°ªì´Á¡C¨Æ¹ê¤W¥Ñ³\¦h³ø§iÅã¥Ü³æ¼h»PÂù¼hªº¿éºëºÞ§k¦XÅã·L¤â³N¡A¦b±µ³q²v»PÃh¥¥ªº¦¨¥\²vµ²ªG¤W¨ÃµLÅãµÛªº®t²§¡C¦Ü©ó³N«áµLºë¤lªº¯f¨Ò¤]¤£¥Î®ð¾k¡A¦³¨Ç¥i¯à·|¦ARecanalization¡A¤j·§¥iÆ[¹î¥b¦~¨ì¤@¦~¡C¥Ñªí¤@¥i²¤ª¾¤@¤G¡G
Table I: Some recent results of vasectomy reversal
Author |
No.of cases |
Patency(%) |
Pregnancy(%) |
Lee & McLaughlin |
41 |
90 |
46 |
¡@ |
26* |
96 |
54 |
Pallon et al. |
36 |
74 |
57 |
Fitzpatrick |
14 |
90 |
64 |
Middletone et al. |
73 |
81 |
49 |
Amelar & Freiha |
83 |
92 |
45 |
Urquhart-Hay |
50 |
84 |
52 |
Cos et al. |
87* |
75 |
46 |
Soonawala & Lai |
194 |
81 |
44 |
¡@ |
339* |
89 |
63 |
Belker et al. |
1012* |
86 |
52 |
Silber |
282* |
91 |
81 |
Meinertz et al. |
145 |
90 |
53 |
Marc Goldstein |
* |
95 |
75 |
* Microsurgical technique.
From W.F.Hendry,Br.J.Urol.1994,
¦ý¬O¦b Vasovasostomy Study Group (1991) ªº¯f¨Ò¤¤¡A¦ü¥G¿éºëºÞ§k¦X
¤â³N«áÃh¥¥²vÀHµÛ¿éºëºÞµ²²Ï¤â³N®É¶¡ªøµu¦³©Ò®t²§¡Aªí¤G¡C
Table 2:Patency and Pregnancy Rates
|
Number of Wives |
|
Number of Men with Pregnant/Number |
Obstructive |
Sperm in Semen/ |
of Couples |
Interval |
No. of Men Followed |
¡@¡@Followed |
(Years) |
(%) |
¡@¡@¡@¡@¡@¡@(%) |
< 3 |
¡@¡@¡@86/89 ¡@¡@(97) |
56/74 |
(76) |
3-8 |
¡@¡@¡@525/600 ¡@(88) |
253/478 |
(53) |
9-14 |
¡@205/261 |
(79) |
¡@92/209 |
(44) |
> 15 |
¡@32/45 |
(71) |
¡@11/37 |
(30) |
From Belker et al. J.Urol.1991.
·íµM Antisperm antibody
¤]¥i¯à·|¼vÅT¿éºëºÞ§k¦X¤â³Nªºµ²ªG¡C¤j·§±µ¨ü¿éºëºÞµ²²Ï¤â³Nªº¯f¤H¡A·|¦³
60% -80% ªº¯f¤H¦³ Antisperm antibody (Hellema,1978;Rose,1979)¡CSullivan»P Howe
µo²{¦b¿éºëºÞ§k¦X¤â³N«á¤Ó¤Ó¦³Ãh¥¥ªº¥ý¥Í¤¤¡A48% ¦³ Antisperm antibody¡F¤Ï¤§¡A¦b¿éºëºÞ§k¦X¤â³N«á¤Ó¤Ó¥¼Ãh¥¥ªº¥ý¥Í¤¤¦³
94% ¦³ Antisperm antibody¡CW.F.Hendry
¤]³ø§i¦b±µ¨ü¿éºëºÞ§k¦X¤â³N«e¦å²M¤¤¦³§ÜÅ骺¬ù 79% ¡A¦Ó Seminal
plasma ¤¤¦³§ÜÅ骺¬° 9.5%,¦ý¿éºëºÞ§k¦X¤â³N«á Seminal plasma
¤¤¦³§ÜÅ骺¬° 29.5%.©Ò¥H§ÜÅé»P¿éºëºÞ§k¦X¤â³NÀ³¬O¦³©ÒÃö³s¡A·íµM³o»P§ÜÅ骺ºØÃþ
IgA ©Î IgG ¦³Ãö¡C¥t¥~¿éºëºÞ§k¦X¤â³N¤¤ Vas fluid
ªº¥~Æ[»Pºë¤l¶q¤]¦³©ÒÃö³s¡Cªí¤T¡C
Table 3: Gross Appearance of Intraoperative Vas Fluid and
Results of Vasovasostomy
|
Results
|
Vas fluid¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@Sperm in
semen |
Pregnancy |
|
|
(n/total) |
(n/total) |
Watery |
16/20 |
¡@(80%) |
5/11 ¡@(45%) |
Cloudy (opalescent) |
¡@¡@¡@9/12 |
(75%) ¡@¡@¡@0/5 |
¡@¡@¡@( 0%) |
Creamy |
7/27 |
¡@(26%) |
6/23¡@(26%) |
From Belker A.M.Contemporary Urol.1993.
µ²½×¡G
Á`µ²¡A¥Ø«e¿éºëºÞ§k¦X¤â³N±µ³q²v¤j·§¥i¹F95%¡A¦ÓÃh¥¥²v¥i¹F75%
ªº¦¨¥\²v¡C¦ý³o¥²»Ý¦³¨}¦nªºÅã·L¤â³N°V½m¡A§_«h¥¢±ÑªºÅã·L¿éºëºÞ§k¦X¤â³N«·s¤â³N¨ä±µ³q²v¥u¦³
70% ,Ãh¥¥ªº¦¨¥\²v¬ù¥u¦³ 45%¡C¦Ü©ó±Ä¥Î¦óºØÅã·L¿éºëºÞ§k¦X¤â³N¡A«h¦]¦U¤Hªº²ßºD»P³ß¦n¡A¥un¬OÅã·L¤â³N¡A®t²§²×¨s¤£¤j¡C¥»¤H´¿©ó¬ü°ê¾Ç²ßÅã·L¤â³N¡A©ó¤p¦Ñ¹«¤§±µ³q²v¤w¹F92%¡A¦b¤HÅ骺¦¨¥\²v¥iª¾¤@¤G¡C
¦^¥»º¶
|